Registered outcomes18

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 18 of 18

List	Outcome	Time frame	Description
Primary	Number of patients that are satisfied with treatment as measured by the credibility and expectancy questionnaire (CEQ	up to 20 weeks	The CEQ is a 6-item measure that asks patients about their perceptions of treatment.
Primary	Number of patients who indicate treatment was acceptable to them (i.e., the treatment approach made sense and was perceived as reasonable)	up to 20 weeks	The Satisfaction with Therapy and Therapist Scale is a 13-item measure that asks patients about their satisfaction with treatment and with their therapist.
Primary	Number of sessions attended	up to 20 weeks	The number of sessions attended will provide an estimate of the feasibility of attending and completing this treatment
Primary	Number of patients who use mindfulness skills assessed by the Southampton Mindfulness Questionnaire (SMQ)	up to 24 weeks	The SMQ is a 16-item measure that asks patients about their use of mindfulness skills .
Primary	Number of patients who use cognitive flexibility skills assessed by the UP Cognitive Skills Questionnaire (CSQ)	up to 24 weeks	The CSQ is a 10-item measure that assesses use of cognitive skills taught in treatment
Primary	Number of Patients who use behavior change skills assessed by the UP Behavioral Avoidance Questionnaire (BAQ)	up to 24 weeks	The BAQ is a five item measure that assesses use of behavior change skills taught in treatment.
Primary	Number of patients who report a decrease in anxiety sensitivity on the Anxiety Sensitivity Index (ASI)	up to 24 weeks	The ASI is an 18 measure that assesses how often a participant experiences anxiety symptoms
Primary	Number of Patients who use behavior change skills assessed by the Brief Experiential Avoidance Questionnaire (BEAQ)	up to 24 weeks	The BEAQ is a 13 item measure that assesses how often a participant avoids emotion-provoking situations
Primary	Change in misophonia symptoms as assessed by the Misophonia Questionnaire	assessed weekly, up to 24 weeks	The Misophonia Questionnaire is a 17-item questionnaire that assesses the presence of misophonia symptoms, emotions and behaviors associated with misophonic reactions, and symptom severity. The first two subscales are rated on a scale of 0 (not at all true) to 4 (always true). These two parts are summed to produce a total score ranging from 0 - 68. The severity subscale is a single item that asks an individual to provide a rating of their sound sensitivity on a scale from 0 (no sound sensitivities) to 15 (very severe sound sensitivities).
Primary	Change in anxiety as measured by the Overall Anxiety Severity and Impairment Scale	assessed weekly, up to 24 weeks	The Overall Anxiety Severity and Impairment Scale is a five item measure that assesses interference and distress related to the experience of anxiety. Items are scored from 0 to 4 and summed to produce a total score (ranging from 0 - 20), with higher scores indicating greater functional impairment.
Primary	Change in depression as measured by the Overall Depression Severity and Impairment Scale	assessed weekly, up to 24 weeks	The Overall Depression Severity and Impairment Scale is a five item measure that assesses interference and distress in an individual's day-to-day life related to the experience of depression. Items are scored from 0 to 4 and summed to produce a total score (ranging from 0 - 20), with higher scores indicating greater functional impairment.
Primary	Change in anger as measured by the PANAS Hostility Scale	assessed weekly, up to 24 weeks	The PANAS Hostility Scale is a 6 item scale that assesses how often a participant experienced anger in the past week.
Secondary	Number of patients who report a change in attentional control as measured by the Digit Span Test	up to 20 weeks	This test assesses a participant's ability to selectively use their attention during a task
Secondary	Number of patients who report a change in attentional control as measured by the Trail Making Test	up to 20 weeks	This test assesses a participant's ability to selectively use their attention during a task
Secondary	Number of patients who report a change in cognitive flexibility as measured by the Stroop test	up to 20 weeks	This test assesses a participant's ability to alternate their responses based on instructions.
Secondary	Number of patients who report a change in cognitive flexibility as measured by the Trail Making Test	up to 20 weeks	This test assesses a participant's ability to alternate their responses based on instructions.
Secondary	Number of seconds participant engaged in a physiological challenge exercise	up to 20 weeks	Participants will be asked to breathe through a small straw, with the option to stop at any time
Secondary	Number of seconds participant engaged in a writing task	up to 20 weeks	Participants will be asked to write about emotion-provoking situations, with the option to stop at any time

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04612374/registered

API reference For AI assistants